AI/ML
April 28, 2026
I’ve been part of more content ROI studies than I can count. The question when things fall flat is always the same: why didn’t the content have more of an impact? The honest answer, more often than not, is that the content reached people. It just didn’t reach the right people, at the right moment, with something that actually meant something to them.
The industry got very good at building and delivering information. That was a real and necessary problem to solve. But relevance was always the harder problem underneath it, and for a long time we could avoid confronting it. Physicians needed the information. Getting it to them felt like enough.
AI changed that calculus. The average physician today can synthesize a drug’s
mechanism of action, review trial endpoints, and pull label data faster than it takes to open a marketing email. The information gap our industry spent 30 years trying to close is effectively gone. Which means the relevance gap, the one we were always dancing around, is now the only gap that matters.
The New Gap Is Relevance
Here’s what AI still can’t do. It can’t tell you that the cardiologist you’re trying to reach has been actively engaging with heart failure decision support content for the last 90 days, has shifted her prescribing behavior in a specific class, and consistently responds to peer-authored case content over manufacturer-produced materials. That’s not something a language model surfaces. That’s behavioral intelligence, built over time, at scale, from real clinical patterns.
At Relevate Health, we’ve spent 15+ years building exactly that. 11.5 billion behavioral data points across the Treatment Perspectives Network capture how physicians actually learn, prescribe, and respond to information. Not how we assume they do. How they demonstrably do.
Sophisticated pharma marketers are already using AI for targeting, and they should be. But brand-owned data has a structural ceiling. It only reflects physicians who already engaged with that brand. Relevate’s behavioral intelligence is built cross-brand, across 15+ years, from how physicians behave across the entire digital landscape. That’s not a gap AI closes. It’s a gap AI widens, for whoever has the better data underneath it.
Content that earns attention in this environment is specific to how a physician in that specialty actually thinks, the patient population they’re managing, and the moment in their workflow when it lands. Relevance isn’t a creative problem. It’s a data problem.
The Curiosity Problem
Physicians aren’t information processors. They’re lifelong learners. The same drive that pushed them through a decade of training doesn’t disappear when they enter practice. It evolves. Hard questions stay interesting. Ambiguous cases still pull at them. The best clinicians aren’t the ones who memorized the most. They’re the ones who never stopped wanting to understand more.
Active learning formats engage that instinct directly. Interactive case simulations, clinical decision games, peer-authored content built around real scenarios. These don’t replace information, they create the cognitive context where information actually sticks. Where a physician doesn’t just recall a data point but knows when and how to use it. It’s the difference between recognizing a statistic and trusting a decision.
AI can answer a clinical question. It can’t replicate the experience of working through one.
What This Means for Your Content Strategy
If you’re a pharma marketer still optimizing for reach and frequency in passive channels, the AI shift should be uncomfortable. The channels aren’t going away, but the bar for earning attention inside them is higher than it’s ever been.
The next round of content ROI studies will separate the brands that adapted from the ones that didn’t. The ones that win won’t have the most content. They’ll have content built on real behavioral intelligence, designed for active engagement, and actually worth a physician’s time.
I still don’t have a perfect answer to why content doesn’t have more impact. But I’m
increasingly convinced the question itself has changed. It’s no longer about whether the information reached the physician. It’s about whether it meant something when it did.